Alzheimer drugs halted
Savings to go to Alzheimer care services
27 June 2018
By Connexion journalistFour Alzheimer drugs costing the health service €90million a year will no longer be reimbursed as the ministry moves to stop them being prescribed due to harmful side effects, which include falls and broken bones.
Savings on Aricept, Ebixa, Exelon, Reminyl and generics will go to Alzheimer care services.
More from French news
More from Connexion
Resident or second-home owner in France?
Benefit from our daily digest of headlines and how-to's to help you make the most of life in France
By joining the newsletter, you agree to our Terms & Conditions and Privacy Policy
1
Shortages of goods in France: What is expected in the months to come?
3 days ago2
Tour de France 2022 route revealed: will it pass near you in France?
2 days ago3
French vaccines and UK contact cases: ‘it’s absurd we must quarantine’
1 day ago4
Which products are – or could be – hit by stock shortages in France?
1 day ago5
Covid-19: Rules for travel to and from France
1 day agoSee more popular articles
The Connexion Help Guides
Income Tax in France 2021 (for 2020 income)*
Brexit and Beyond for Britons in France*
Editor's Picks
What are post-Brexit rules for moving items from a French house to UK?
14 October 2021
Which fruit and veg cannot be sold under plastic in France from 2022?
12 October 2021
France leaves open possibility of health pass until July 31, 2022
13 October 2021
Brittany’s historic stones vying for World Heritage status
14 October 2021
French ‘RoboCrop’ pilot scheme could be solution for small-scale farms
15 October 2021
More from French news
More from Connexion
Get news, views and information from France
